PT-141

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist originally derived as a metabolite of Melanotan II. It selectively activates melanocortin receptors MC1R and MC4R, which are expressed throughout the central nervous system and have been studied in the context of appetitive behaviour signalling, melanogenesis, and hypothalamic neuropeptide regulation. PT-141's unique mechanism of action — operating through the melanocortin system rather than vascular pathways — has made it a subject of significant interest in receptor pharmacology and GPCR signalling research. Supplied as a >99% purity lyophilised powder (10mg).

This product is intended strictly for laboratory research use only. It is not approved for human or veterinary consumption or for use in diagnostic or therapeutic procedures.

• Purity: >99%
• Form: Lyophilised powder
• Intended use: Laboratory research only